Calls for papers
-
Actavis has announced that it is relaunching 0.25 and 0.5 mg vials of budesonide inhalation suspension, a generic version of AstraZeneca’s Pulmicort Respules, after the United States Court of Appeals for the Federal Circuit lifted… Read more . . .
-
Pennsylvania-based Egalet Corporation has announced that it will begin promoting Sprix ketorolac tromethamine nasal spray in the second quarter of 2015. Sprix is a non-steroidal anti-inflammatory drug (NSAID) for the short-term treatment of moderate to… Read more . . .
-
Timer Designs, a Dutch company specializing in compliance devices, has introduced a new version of its Compliance Cradle for Breo Ellipta, which GSK will supply with the inhaler, the company said. The cradle uses an… Read more . . .
-
Capsugel has announced that Bend Research, which Capsugel acquired in September 2013, has manufactured Phase 2 clinical trial supplies of a DPI formulation, its first inhalation product manufactured at that scale. The biopharmaceutical formulation was… Read more . . .
-
Advanced Inhalation Therapies (AIT) has announced that its AIT-CF high dose inhaled formulation of nitric oxide (NO) for the treatment of cystic fibrosis has been granted orphan medical product designation by the European Commission. In… Read more . . .
-
The FDA has approved GSK’s supplemental NDA for the Breo Ellipta fluticasone furoate/vilanterol DPI, allowing GSK to market the inhaler for the treatment of asthma in patients aged 18 years and older. Breo Ellipta was… Read more . . .
-
Inhaled drug developer Alexza Pharmaceuticals has announced the promotions of Edwin S. Kamemoto to Executive VP, R&D and Quality and Lori H. Takahashi to VP, Pharmaceutical R&D and Quality. Both positions are newly created. Kamemoto… Read more . . .
-
California-based InCarda Therapeutics (formerly Pleiades Cardio-Therapeutics) has announced that it raised over $5 million with the possibility of an additional $1.5 million in a private financing round led by Morningside Venture. According to the company,… Read more . . .
-
Inhalation Sciences AB (ISAB) has announced that the 3D module of its PreciseInhale dry powder aerosol testing system is now called “XposeALI.” Using air liquid interface (ALI) technology, ISAB creates 3D models with primary epithelial… Read more . . .
-
ASTM International’s Subcommittee on Characterization and Handling of Powders and Bulk Solids has published a new standard titled “Standard Test Method for Shear Testing of Powders using the Freeman Technology FT4 Powder Rheometer Shear Cell.”… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA